Crossref
Prionogenicity of vimentin surmised from the sequelog of anti-idiotypic antibodies toward the paratope of malignant-associated autologous anti-vimentin antibody, CLN-IgG (Pritumumab)
British Journal of Cancer Research · 2018
DOI: 10.31488/bjcr.1000104 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Cancer Research, 2018.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2018). Prionogenicity of vimentin surmised from the sequelog of anti-idiotypic antibodies toward the paratope of malignant-associated autologous anti-vimentin antibody, CLN-IgG (Pritumumab). British Journal of Cancer Research. https://doi.org/10.31488/bjcr.1000104
Vancouver
Prionogenicity of vimentin surmised from the sequelog of anti-idiotypic antibodies toward the paratope of malignant-associated autologous anti-vimentin antibody, CLN-IgG (Pritumumab). British Journal of Cancer Research. 2018. doi:10.31488/bjcr.1000104
BibTeX
@article{euvimed2018,
title = {Prionogenicity of vimentin surmised from the sequelog of anti-idiotypic antibodies toward the paratope of malignant-associated autologous anti-vimentin antibody, CLN-IgG (Pritumumab)},
journal = {British Journal of Cancer Research},
year = {2018},
doi = {10.31488/bjcr.1000104}
}
EUVIMED